Stephen Pawsey
Plus aucun poste en cours
Historique de carrière de Stephen Pawsey
Anciens postes connus de Stephen Pawsey
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NIOX GROUP PLC | Directeur Technique/Scientifique/R&D | 01/01/2014 | - |
| Pharmagene Plc | Directeur Technique/Scientifique/R&D | - | - |
| Corporate Officer/Principal | - | 11/04/2011 | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/01/2014 | - |
| VERNALIS | Corporate Officer/Principal | 22/11/2010 | - |
Formation de Stephen Pawsey
| University of London | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NIOX GROUP PLC | Health Services |
| Entreprise privées | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| Pharmagene Plc | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Stephen Pawsey
- Expérience
